DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more


Nutrilib.com
A comprihensive source of nutritional information

Randomized Study of Exercise and Vitamin D in Frail Elderly Subjects.

Information source: Pfizer
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Elderly, Frail

Intervention: Vitamin D + Sham Exercise (Drug); Vitamin D Placebo + Exercise (Procedure); Vitamin D Placebo + Sham Exercise (Procedure); Vitamin D + Exercise (Drug)

Phase: N/A

Status: Terminated

Sponsored by: Pfizer

Official(s) and/or principal investigator(s):
Pfizer CT.gov Call Center, Study Director, Affiliation: Pfizer

Summary

The study will explore multiple mobility function tests as well as functional and neuropsychological tests in elderly subjects at risk for falls and disability, before and after 4-month exercise and/or Vitamin D intervention.

Clinical Details

Official title: Evaluation of the Effect of a 4-Month Intervention of Exercise and/or Vitamin D on Mobility Function and Strength in Frail Elderly Subjects

Study design: Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Parallel Assignment, Efficacy Study

Primary outcome: Characterization of effect of 4-month exercise and/or Vitamin D intervention on mobility function and strength in frail elderly subjects.

Secondary outcome: Evaluation of utility and variability of mobility function tests and biomarekrs, as well as explore the predictors for the exercise and/or Vitamin D intervention response in frail elderly subjects.

Eligibility

Minimum age: 75 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Elderly subjects with moderate frailty residing in assisted living facilities.

Exclusion Criteria:

- Presence of progressive, unstable chronic disease; hyperparathyroidism,

hypercalcemia.

Locations and Contacts

Pfizer Investigational Site, Farmington, Connecticut 06030-5215, United States

Pfizer Investigational Site, Hyattsville, Maryland 20782, United States

Pfizer Investigational Site, Roslindale, Massachusetts 02131-1011, United States

Pfizer Investigational Site, New York, New York 10040-3403, United States

Additional Information

To obtain contact information for a study center near you, click here.

Starting date: October 2005
Ending date: January 2008
Last updated: May 8, 2008

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008